VYNE Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2025 | 1.39 M | $2.37 M | 0.00% | 3.27% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.10 M | $1.74 M | -10.58% | 2.58% |
| 05/19/2025 | 785.94 K | $1.24 M | 71.99% | 1.84% | |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 636.10 K | $1.01 M | 100.00% | 1.49% |
| VANGUARD GROUP INC | 05/09/2025 | 475.65 K | $751.53 K | 0.11% | 1.11% |
| EXOME ASSET MANAGEMENT LLC | 05/16/2025 | 462.80 K | $731.23 K | 30.94% | 1.08% |
| PALO ALTO INVESTORS LP | 05/15/2025 | 445.43 K | $703.79 K | 0.00% | 1.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 344.13 K | $543.73 K | 123.27% | 0.81% |
| PATIENT SQUARE CAPITAL LP | 05/14/2025 | 257.03 K | $406.11 K | 100.00% | 0.60% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2025 | 217.98 K | $344.41 K | 42.49% | 0.51% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 141.50 K | $223.57 K | 138.22% | 0.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 133.49 K | $210.93 K | -1.13% | 0.31% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 115.14 K | $181.93 K | 361.62% | 0.27% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 84.98 K | $134.26 K | -51.90% | 0.20% |
| BLACKROCK, INC. | 05/02/2025 | 82.58 K | $130.47 K | -0.88% | 0.19% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 70.42 K | $111.26 K | 100.00% | 0.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 57.76 K | $91.26 K | -18.45% | 0.14% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 51.96 K | $82.09 K | 40.59% | 0.12% |
| STALEY CAPITAL ADVISERS INC | 05/12/2025 | 51.47 K | $81.33 K | 41.13% | 0.12% |
| UBS OCONNOR LLC | 05/15/2025 | 45.56 K | $71.98 K | -81.47% | 0.11% |
| XTX TOPCO LTD | 05/08/2025 | 33.05 K | $52.22 K | 57.26% | 0.08% |
| HRT FINANCIAL LP | 05/15/2025 | 26.24 K | $41.00 K | 100.00% | 0.06% |
| NORTHERN TRUST CORP | 05/13/2025 | 23.97 K | $37.87 K | 0.00% | 0.06% |
| VIRTU FINANCIAL LLC | 05/12/2025 | 19.57 K | $31.00 K | 100.00% | 0.05% |
| COMMONWEALTH EQUITY SERVICES, LLC | 05/09/2025 | 18.30 K | $29.00 K | 0.00% | 0.04% |
| SHAY CAPITAL LLC | 05/15/2025 | 18.02 K | $28.46 K | 100.00% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 17.16 K | $27.12 K | 1,051.11% | 0.04% |
| STATE STREET CORP | 05/15/2025 | 15.77 K | $24.91 K | 0.00% | 0.04% |
| MORGAN STANLEY | 05/15/2025 | 12.81 K | $20.24 K | 198.00% | 0.03% |
| UBS GROUP AG | 05/13/2025 | 7.58 K | $11.97 K | 1,100.63% | 0.02% |
| JPMORGAN CHASE & CO | 05/12/2025 | 5.98 K | $9.45 K | 1,804.78% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 4.30 K | $6.79 K | 209.96% | 0.01% |
| ROYAL BANK OF CANADA | 05/15/2025 | 2.44 K | $4.00 K | -90.33% | 0.01% |
| 05/07/2025 | 1.04 K | $1.65 K | 0.00% | 0.00% | |
| CWM, LLC | 05/01/2025 | 500 | $1.00 K | 0.00% | 0.00% |
| CENTERPOINT ADVISORS, LLC | 05/13/2025 | 350 | $1.00 K | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 65 | $103 | 0.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 05/14/2025 | 25 | $40 | 100.00% | 0.00% |
| FMR LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/19/2025 | 0 | $0 | -100.00% | 0.00% |
| BFSG, LLC | 04/18/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
VYNE Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 48 institutional investors and hedge funds held shares of VYNE Therapeutics Inc.. The most heavily invested institutionals were:
EVENTIDE ASSET MANAGEMENT, LLC: 1.39 M
CITADEL ADVISORS LLC: 1.1 M
DAFNA Capital Management LLC: 636,103
VANGUARD GROUP INC: 475,650
Exome Asset Management LLC: 462,801
Palo Alto Investors LP: 445,434
16.78% of VYNE Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 7.54 M shares in the last 24 months. This purchase volume represents approximately $10.74 M in transactions.